Vilket är priset för Scilex Holding Company (SCLX)

Priset för Scilex Holding Company (SCLX) är $5.61

Vilket är marknadsvärdet för Scilex Holding Company (SCLX)

Marknadsvärdet för Scilex Holding Company (SCLX) är $47.65M

Scilex Holding Company (SCLX) Aktiesplittar

Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by persistent nerve pain following shingles. Beyond this, the company's development pipeline includes SP-102, a viscous gel corticosteroid for epidural administration, currently undergoing Phase III trials for lumbosacral radicular pain. Another candidate, SP-103, is progressing through Phase II trials for managing low back pain. Furthermore, SP-104, a novel, low-dose, delayed-release naltrexone hydrochloride formulation, has successfully concluded Phase I clinical testing for the treatment of fibromyalgia. Its corporate offices are situated in Palo Alto, California. Scilex Holding Company operates as a subsidiary of Sorrento Therapeutics, Inc.

År	Split	Multipel	Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.

År

Split

Multipel

Kumulativ multipel

Inte tillräckligt med data för de angivna datumen.

Företag	Antal aktiesplitar	Kumulativ multipel	Land
Eli Lilly and Company LLY.US	4	x15	US
Johnson & Johnson JNJ.US	7	x432	US
AbbVie Inc. ABBV.US	0	-	US
Roche Holding AG RO.SW	2	x10000	CH
Merck & Co., Inc. MRK.US	7	x226	US

Företag

Antal aktiesplitar

Kumulativ multipel

Land